2017
$87M
from 10 investors over 10 rounds
Terns Pharmaceuticals raised $87M on January 5, 2021
Investors: Samara Capital, Suvretta Capital Management LLC, Lilly Asia Ventures, OrbiMed Advisors and Vivo Capital
Terns Pharmaceuticals raised $80M on October 30, 2018
Investors: Lilly Asia Ventures, Decheng Capital, Vivo Capital and OrbiMed Advisors
Terns Pharmaceuticals raised $30M on April 4, 2018
Investors: Lilly Asia Ventures